Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The MS data for anti-LZTFL1 with or without ferroptosis induction

ABSTRACT: anti-LZTFL1 pulldown protein analysed by MS. NCI-H1299 cells were treated with DMSO or erastin for 8 hours..

ORGANISM(S): Homo Sapiens

SUBMITTER: Jiayi Wang

PROVIDER: PXD054848 | iProX | Thu Sep 19 00:00:00 GMT+01:00 2024

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

MS for anti-G6PD with or without ferroptosis induction

Project description:MS for anti-G6PD with or without ferroptosis. NCI-H1299 cells were treated with DMSO or erastin for 8 hours.

2024-09-19 | PXD054838 |

IP-MS data for identifying oxidation site of YY1 under ferroptosis induction

Project description:Nuclear proteins were extracted from relative ferroptosis-resistant cell (A549) following treating with DMSO or erastin(10 μM, 10 hours) with or without treatment of Fer-1 and immunoprecipitated by anti-YY1 antibody for LC-MS/MS proteomics analysis to identify oxidation site of YY1 under ferroptosis induction.

2026-01-10 | PXD072939 |

Human H1299 lung carcinoma cells treated with AVJ16 or DMSO (vehicle)

Project description:H1299 cells were treated with 1.5uM AVJ16 or DMSO for 96 hours and then analyzed by MS

2025-09-01 | PXD054641 | Pride

Erastin-Induced Ferroptosis Enhances Natural Killer Cell Anti-Tumor Activity and Offers Therapeutic Potential in Neuroblastoma

Project description:High-risk neuroblastoma (NB) often relapses and becomes refractory to treatment, making it a significant contributor to childhood cancer mortality despite its relative rarity. Addressing the challenges posed by NB’s resistance to conventional apoptosis-inducing therapies (e.g., chemotherapy and radiation) has become a pressing concern in pediatric oncology research. In recent years, the growing comprehension of alternative cell death modalities distinct from apoptosis has revealed a promising avenue in the endeavor to combat treatment-resistant cancers. One such mechanism, ferroptosis, has attracted increasing attention for its potential role in combating therapy-resistant cancer cells. High-risk NB typically exhibits an immune-excluded phenotype, characterized by minimal immune cell infiltration. Despite this characteristic, the mechanisms underlying immune exclusion and impaired immune activation in NB remain unclear. Here, we demonstrate that the induction of ferroptosis using Erastin, a cysteine-glutamate antiporter inhibitor, reduces NB cell proliferation and foci formation. Furthermore, our transcriptomics analysis revealed that treatment with Erastin in NB cells led to increased expression of ULBP1, a ligand to the activating natural killer (NK) cell receptor, NKG2D. Upon ferroptosis induction, the transcription factor ATF4 was found to drive ULBP1 expression in NB cells. Consistent with this, pre-treatment with Erastin sensitized NB cells to NK cell cytotoxicity in co-culture experiments. These results suggest the NK cell’s cytotoxic function can be enhanced with Erastin-mediated ferroptosis, which may be beneficial for NB patients.

2026-02-12 | GSE317656 | GEO

LC-MS/MS proteomics data for identifying anti-ferroptosis regulators

Project description:Cytoplasmic and nuclear proteins were extracted from relative ferroptosis-resistant cell (A549) and relative ferroptosis-sensitive cell (Calu-1) with or without the treatment of erastin (10 μM, 10 hours) for LC-MS/MS proteomics analysis to identify potential anti-ferroptosis regulators that entered nucleus from cytoplasm under ferroptosis induction.

2026-01-11 | PXD072927 |

3D gene regulation network in glioma ferroptosis

Project description:Erastin is a small molecular compound which inhibits the system Xc- and prevents the import of cystine, reducing glutathione (GSH) biosynthesis and glutathione peroxidase 4 (GPX4) activity, and finally inducing cell death via ferroptosis. To establish a model of Erastin induced ferroptosis in glioma cells, U87 cells were treated of Erastin (10 μM, 72 h). Combination analysis of HiChIP, ChIP-seq and RNA-seq data suggests that change of chromatin loops mediated by 3D chromatin structure regulate gene expressions in glioma ferroptosis. Genes that regulated by 3D chromatin structure include genes that were reported function in ferroptosis like MDM2 and TXRND1. We propose a new regulatory mechanism governing glioma cell ferroptosis by 3D chromatin structure.

2023-10-23 | GSE236253 | GEO

Genome-wide analysis of ferroptosis related genes in liver cancer cells.

Project description:To seek ferroptosis related genes in liver cancer cells, we treated HepG2 cells using ferroptosis inducer Erastin and inhibitor Ferrostatin, respectively. We found that a subset of genes were up-regulated in Erastin treatment groups and down-regulated in Ferrostatin treatment groups, suggesting that these genes might be correlated with ferroptosis.

2019-06-10 | GSE104462 | GEO

Chemotherapy response in cholangiocarcinoma

Project description:CCLP cholangiocarcinoma cells were transfected with CTRL inhibitor or MIR1249 inhibitor for 48 hours and treated with DMSO or chemotherapy (cisplatin and gemcitabine) for 48 hours before being collected and analysed for gene expression

2022-06-06 | GSE132328 | GEO

Photo-Enhanced Synergistic Induction of Ferroptosis for Anti-Cancer Immunotherapy.

Project description: Not available

| S-EPMC11468986 | biostudies-literature

ApoE isoforms differentially alter baseline antioxidant levels critical to ferroptosis mitigation

Project description:U87 cells overexpressing ApoE isoforms were treated with sulforaphane for 18 hours for comparison with a DMSO control. ApoEChimp is on the ApoE4 backbone but contains R61T which is thought to be the isoform defining residue.

2026-06-30 | E-MTAB-16242 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data